Viasat Inc: Form 10-Q for the period ended Dec 31, 2024
Filed with the SEC on Feb 10, 2025 and accepted by EDGAR at Feb 10, 2025, 20:53 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-10-01 to 2024-12-31 | $1.12bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2024-04-01 to 2024-12-31 | $3.37bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2024-10-01 to 2024-12-31 | $36.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-04-01 to 2024-12-31 | $108.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-10-01 to 2024-12-31 | $238.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-04-01 to 2024-12-31 | $761.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-10-01 to 2024-12-31 | $21.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-04-01 to 2024-12-31 | $56.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-10-01 to 2024-12-31 | $94.5m | us-gaap:InterestExpense |
| Interest expense | 9 months2024-04-01 to 2024-12-31 | $315.6m | us-gaap:InterestExpense |
| Income tax | 3 months2024-10-01 to 2024-12-31 | −$11.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-04-01 to 2024-12-31 | −$4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-10-01 to 2024-12-31 | −$158.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-04-01 to 2024-12-31 | −$328.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-10-01 to 2024-12-31 | −$1.23 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-04-01 to 2024-12-31 | −$2.57 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-10-01 to 2024-12-31 | −$1.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-04-01 to 2024-12-31 | −$2.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-10-01 to 2024-12-31 | 128,941,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-04-01 to 2024-12-31 | 127,968,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-04-01 to 2024-12-31 | $609.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2024-12-31 | $1.56bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $2.84bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $15.60bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $1.58bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $10.75bn | us-gaap:Liabilities |
| Current portion of debt | At period end2024-12-31 | $506.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-12-31 | $4.76bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-016993. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.